Latest Industry Insights

This article examines the impact of the democratization of computational design and discusses how synthetic biology companies must shift focus if they are to remain competitive.

New applications for RNA therapeutics are continuously emerging. In this burgeoning space, nucleic acid quantification can help this dynamic therapeutic modality reach its full potential.

Trial sponsors are faced with vast amounts of diverse data and corresponding endpoints spanning all trial sites linked to their study design. This article explores how interactive response technology can help sponsors overcome these challenges.

This article discusses why the proactive detection and monitoring of viral threats through genomics studies is vital in preventing future pandemics and empowering healthcare providers in the face of increasing globalization.

At AACR 2023, Technology Networks spoke with Dr. Mark Garner, global cancer segment market manager at Agilent Technologies, to learn how the new SureSelect Cancer CGP assay is empowering the cancer research field.

At ASMS, Technology Networks spoke with Ken Suzuki and Jennifer Gushue to learn more about how Agilent is addressing customer needs with novel “intelligence” features and the company’s efforts to ensure the sustainability and longevity of its products.

Researchers have made significant strides toward developing improved battery chemistries, but scaling up production is challenging. To find out more, we spoke to Zhao Liu, senior market development manager at Thermo Fisher Scientific.

Technology Networks recently spoke with Tom Schafer, Vice President at Koch Modular Process Systems, to learn more about the pongamia tree, how its bitter taste can be processed out and the potential uses for pongamia oil.

At ASMS 2023, Technology Networks spoke with Dr. Chris Lock, vice president of global research and development at SCIEX, to discuss the newly launched Intabio ZT system.

At ASMS 2023, Technology Networks spoke with Jim Yano, senior director of product management at Thermo Fisher Scientific, to learn more about the company's novel instrument launches and how they could be applied to personalized medicine.